Bill
HB 6814
Overview: HB 6814, AN ACT CONCERNING PHARMACY BENEFITS MANAGER REFORM, was referred to the Joint Committee on Insurance and Real Estate on January 29, 2025.Purpose and Intent: The
Overview: HB 6814, AN ACT CONCERNING PHARMACY BENEFITS MANAGER REFORM, was referred to the Joint Committee on Insurance and Real Estate on January 29, 2025.
Purpose and Intent: The bill aims to introduce reforms to the regulation and oversight of pharmacy benefits managers (PBMs) in the state. PBMs are intermediaries that manage prescription drug benefits on behalf of health plans and insurers.
Key Provisions:
- Requires PBMs to be licensed and regulated by the state insurance department.
- Mandates increased transparency from PBMs, including the disclosure of financial arrangements and the reporting of drug pricing information.
- Prohibits PBMs from engaging in certain practices, such as "gag clauses" that restrict pharmacists from informing patients about lower-cost options.
- Establishes an appeals process for pharmacies and patients to challenge PBM decisions.
Affected Parties and Impacts: The bill would affect PBMs, health plans, insurers, pharmacies, and consumers. It is intended to increase competition, reduce costs, and improve access to affordable prescription drugs.
Procedural and Timeline Considerations: The bill has been referred to the Joint Committee on Insurance and Real Estate for further review and consideration. If passed, the new PBM regulations and requirements would likely be implemented over a specified timeline.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
